Actemra and Multiple myeloma - a phase IV clinical study of FDA data

Summary:

Multiple myeloma is reported as a side effect among people who take Actemra (tocilizumab), especially for people who are female, 60+ old, have been taking the drug for 2 - 5 years also take Ativan, and have Diabetes.

The phase IV clinical study analyzes which people have Multiple myeloma when taking Actemra. It is created by eHealthMe based on reports of 102,551 people who have side effects when taking Actemra from the FDA, and is updated regularly.

What is Actemra?

Actemra has active ingredients of tocilizumab. It is often used in rheumatoid arthritis. eHealthMe is studying from 102,759 Actemra users. Check the latest studies of Actemra.

What is Multiple myeloma?

Multiple myeloma (cancer of the plasma cells) is found to be associated with 1,107 drugs and 1,404 conditions by eHealthMe. Check the latest studies of Multiple myeloma.

On Aug, 04, 2026

102,551 people reported to have side effects when taking Actemra.
Among them, 13 people (0.01%) have Multiple myeloma.

Among these 13 people:

How long have people been on Actemra when they have Multiple myeloma? *

What is the gender of people who have Multiple myeloma when taking Actemra? *

female: 54.55 %
male: 45.45 %

What is the age of people who have Multiple myeloma when taking Actemra? *

What are other drugs people take besides Actemra? *

What are other side effects people have besides Multiple myeloma? *

High Blood Pressure: 3 people, 23.08%
Weight Increased: 2 people, 15.38%
Joint Pain: 2 people, 15.38%
Blister Infected (infection of small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure): 2 people, 15.38%
Blood Pressure Diastolic Increased: 2 people, 15.38%
Blood Pressure Fluctuation: 2 people, 15.38%
Bronchitis (inflammation of the mucous membrane in the bronchial tubes): 2 people, 15.38%
Cellulitis (infection under the skin): 2 people, 15.38%
Eye Infection: 2 people, 15.38%
Foot Fracture: 2 people, 15.38%

What are the existing conditions these people have? *

Temporal Arteritis (inflammation and damage to blood vessels that supply the head area): 1 person, 7.69%
Systemic Sclerosis (Scleroderma) (an autoimmune or connective tissue disease. it is characterized by thickening of the skin): 1 person, 7.69%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 1 person, 7.69%
Diabetes: 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Actemra and have Multiple myeloma?

- Check whether Multiple myeloma is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Actemra:

Actemra (102,759 reports)

Multiple myeloma treatments and more:

Multiple myeloma (516,725 reports)

Browse all side effects of Actemra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Multiple myeloma:

Multiple myeloma (1,107 drugs)

Browse all the conditions that are associated with Multiple myeloma:

Multiple myeloma (1,404 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on tocilizumab (the active ingredients of Actemra) and Actemra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.